The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

NCT06620809 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica Spectrum Disorders

Interventions

DRUG: Extracellular vesicles derived from human-induced neural stem cells for intrathecal injection
DRUG: A placebo of extracellular vesicles derived from human-induced neural stem cells for intrathecal injection

Sponsor

Tongji Hospital

Collaborators

[object Object]